China’s Alebund Pharmaceuticals snaps over $29m in a pre-Series C round

China’s Alebund Pharmaceuticals snaps over $29m in a pre-Series C round

Image by Myriam Zilles from Unsplash.

14 April, 2023

Edited by: Joymitra Rai

H Health Investment Lilly Asia Ventures Octagon Capital Quan Capital Verition Fund

Printed by Unregistered user on Tue, 09 Dec 2025 13:06:22 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China Digest: ZJLD eyes up to $900m in HK IPO; Future Dao going public

Venture Capital

China Digest: LeeKr Technology, SENSilicon secure funding

Read more from Greater China

Venture Capital

Pop Mart backer Vision Knight Capital raises over $560m for new funds

Venture Capital

Tencent-backed SanegeneBio secures over $110m Series B